title: Iatrogenic Creutzfeldt-Jakob disease from commercial cadaveric human growth hormone.
authors.forename: Brian S
authors.initials: BS
authors.lastname: Appleby
authors.forename: Mei
authors.initials: M
authors.lastname: Lu
authors.forename: Alberto
authors.initials: A
authors.lastname: Bizzi
authors.forename: Michael D
authors.initials: MD
authors.lastname: Phillips
authors.forename: Sally M
authors.initials: SM
authors.lastname: Berri
authors.forename: Madeleine D
authors.initials: MD
authors.lastname: Harbison
authors.forename: Lawrence B
authors.initials: LB
authors.lastname: Schonberger
mesh_terms: D000328:Adult; D002102:Cadaver; D007562:Creutzfeldt-Jakob Syndrome / Q000139:chemically induced* / Q000473:pathology; D017809:Fatal Outcome; D019382:Human Growth Hormone / Q000009:adverse effects* / Q000302:isolation & purification; D006801:Humans; D007049:Iatrogenic Disease; D055256:Infectious Disease Incubation Period; D008297:Male; D011328:Prions / Q000302:isolation & purification / Q000472:pathogenicity*
chemical_list: D011328:Prions; D019382:Human Growth Hormone
keywords: Creutzfeldt-Jakob disease; cadaveric; case report; commercial; human growth hormone; iatrogenic Creutzfeldt-Jakob disease; prions and related diseases